Related Links Educational Materials About Clinical Trials Clinical Trials: Questions and Answers Questions to Ask Your Doctor Drug Information from MedlinePlus

Alternate Title
Basic Trial Information
Trial Description
     Purpose
     Eligibility
     Treatment/Intervention
Trial Contact Information
Registry Information

Alternate Title

Phase III Randomized Study of a Dietary Supplement Comprising Selected Vegetables-Sun's Soup in Patients With Stage IIIB or IV Non-Small Cell Lung Cancer Undergoing Treatment With Best Supportive Care

Basic Trial Information

Phase Type Status Age Sponsor Protocol IDs Phase III Treatment Approved-not yet active 18 and over Other SFC-SV002 NCT00246727

Trial Description

Purpose:

Selected vegetables- Sun's soup dietary supplement contains ingredients that may slow the growth of non-small cell lung cancer. It is not yet known whether selected vegetables-Sun's soup dietary supplement is more effective than a placebo in treating non-small cell lung cancer.

This randomized phase III trial is studying selected vegetables-Sun's soup dietary supplement to see how well it works compared with a placebo in treating patients who are undergoing supportive care (radiation therapy, surgery, or palliative care) for stage IIIB or stage IV non-small cell lung cancer.

Eligibility:

Eligibility criteria include the following:

• At least 18 years old
• No more than 2 months since diagnosis
• Unwilling to receive chemotherapy
• Able to eat solid food
• More than 5 years since chemotherapy
• For more information about the eligibility criteria for this trial, refer to the Health Professional version.

Final eligibility for a clinical trial is determined by the health professionals conducting the trial.

Treatment/Intervention:

Patients will be randomly assigned (have an equal chance of being placed) to one of two treatment groups.

Patients in group one will receive selected vegetables-Sun's soup dietary supplement by mouth once a day for up to 3 years.

Patients in group two will receive a placebo by mouth once a day for up to 3 years.

All patients will also receive radiation therapy, surgery, and palliative care for 3 years.

Quality of life will be assessed periodically for approximately 22 months. After finishing treatment, patients will be evaluated periodically.

Important:

For more details about this trial, refer to the Health Professional version of the trial summary.

If you are interested in participating in a clinical trial, contact your doctor for a referral or call a trial contact person listed below. You may see the same contact person listed at more than one site, however, if you call the number listed you can ask to speak to the study coordinator or person involved with the specific trial you are interested in. If you have questions about cancer or clinical trials, call the Cancer Information Service at 1-800-4-CANCER (1-800-422-6237). General information about clinical trials, including risks, benefits, and costs, can be found on NCI's Web site.

Trial Contact Information

Trial Lead Organizations

Sun Farm Corporation

Henry Sacks, MD, PhD, Principal investigator		Ph: 212-241-7856 Email: henry.sacks@mssm.edu

Registry Information
Official Title		Effects of a Dietary Supplement (SV) on Advanced Non Small Cell Lung Cancer Patients Treated with Best Supportive Care (BSC): A Randomized Double-Blind Placebo Controlled Study
Trial Start Date		2008-03-01 (estimated)
Trial Completion Date		2011-12-31 (estimated)
Registered in ClinicalTrials.gov		NCT00246727
Date Submitted to PDQ		2006-10-17
Information Last Verified		2007-12-13

Back to Top